š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
This multi-center, randomized, double blind, parallel-group, placebo-contro...
Status
Completed
Location
Multiple Locations
Start Date
2010-12
Trial ID
NCT01192906
Treatments Being Tested
To evaluate the safety and tolerability of single dose of SYH2082 Injection...
Status
Active Not Recruiting
Location
The Affiliated Hospital of Nanjing University Medical School
Start Date
2026-04-13
Trial ID
NCT07736404
Treatments Being Tested
This is a randomized, double-blind, placebo-controlled, parallel-group stud...
Status
Active Not Recruiting
Location
Shanghai Dermatology Hospital
Start Date
2024-09-23
Trial ID
NCT06554847
Treatments Being Tested
Leaders in Action (LIA) is a norms-centered intervention that aims to reduc...
Status
Completed
Location
Innovations for Poverty Action
Start Date
2022-05-02
Trial ID
NCT05331248
Treatments Being Tested
Evaluate the safety and tolerability of VX-659 in healthy subjects...
Status
Completed
Location
Multiple Locations
Start Date
2016-11
Trial ID
NCT03029455
Treatments Being Tested
The primary purpose of this study is to evaluate the effect of the up-titra...
Status
Completed
Location
SGS Clinical Pharmacology Unit (located in ZNA Stuivenberg)
Start Date
2019-03-20
Trial ID
NCT03882255
Treatments Being Tested
This study aims to evaluate the ability of swept-source optical coherence t...
Status
Completed
Location
Multiple Locations
Start Date
2016-06-21
Trial ID
NCT07690644
The primary objective of the study is to evaluate the efficacy of a booster...
Status
Enrolling By Invitation
Location
Cantonal Hospital Aarau
Start Date
2023-11-13
Trial ID
NCT06037564
Treatments Being Tested
The purpose of this study is to characterize the effects of 85 days treatme...
Status
Withdrawn
Location
Multiple Locations
Start Date
2015-05-20
Trial ID
NCT02410499
Treatments Being Tested